Publications by authors named "Eva Hubmann"

Claim this Profile
A
Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1.
Christoph Robier, Gerald Hoefler, Kristina Aubell, Eva Hubmann

Ann Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Gerald W Prager, Leopold Oehler, Armin Gerger, Brigitte Mlineritsch, Johannes Andel, Eva Hubmann

Eur J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: analysis of an Austrian multicenter, noninterventional study.
Jakob Michael Riedl, Florian Posch, Gerald Prager, Wolfgang Eisterer, Leopold Oehler, Eva Hubmann

Ther Adv Med Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical "hairy cell-like" presentation of leukemic mantle cell lymphoma.
Christoph Robier, Gerald Hoefler, Margot Egger, Eva Hubmann

Clin Chem Lab Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Nataliya Vytrva, Elvira Stacher, Peter Regitnig, Wilma Zinke-Cerwenka, Sabine Hojas, Eva Hubmann

Arch Pathol Lab Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.
Christoph Tinchon, Eva Hubmann, Angelika Pichler, Felix Keil, Martin Pichler

Acta Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis